Announcements Trials

Browse Landscape

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 1 Carcinoma, Squamous Cell 1

Interventions

Cisplatin 2 ponatinib 1 pembrolizumab 1 Surgical Procedures, Operative 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Platinum 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Induction Chemotherapy 1 Hydroxyurea 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 Erlotinib Hydrochloride 1 Biopsy 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Carcinoma, Squamous Cell × Hydroxyurea × Clear all

NCT01211938 2017-05-16

JANORL2

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2/3 Completed

Carcinoma, Squamous Cell, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡